CompanyGraph
Prestige Consumer Healthcare Inc.
PBH · NYSE Arca · United States
prestigebrands.comFinancials as of FY2026
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $2.21B, above the global median of $1.18B
- FinancialsAltman Z-Score 2.23: grey zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.21BUSDvs all stocks (USD)
Trailing P/E
13.06xRevenue (TTM)
1.10BUSDvs all stocks (USD)
Profit Margin
15.57%Beta
0.3310xvs all stocks
52-Week Change
-24.76%vs all stocks
Market Capitalization
2.21BUSDvs all stocks (USD)
Enterprise Value
4.19BUSDvs all stocks (USD)
Trailing P/E
13.06xForward P/E
9.17xPEG Ratio
-0.3581xPrice to Sales (TTM)
2.00xPrice to Book (MRQ)
1.15xEnterprise to Revenue
3.79xEnterprise to EBITDA
12.87xGross Margin
51.25%Profit Margin
15.57%Operating Margin
20.83%Return on Assets (TTM)
4.58%Return on Equity (TTM)
9.12%Revenue (TTM)
1.10BUSDvs all stocks (USD)
Revenue per Share (TTM)
23.04USDUpdated Sep 28, 2026Quarterly Revenue Growth
6.50%Gross Profit (TTM)
605.18MUSDvs all stocks (USD)
EBITDA (TTM)
312.70MUSDvs all stocks (USD)
Net Income (TTM)
172.01MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-38.50%Operating Cash Flow (TTM)
249.40MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
147.89MUSDvs all stocks (USD)
Payout Ratio
0.00%Revenue
1.09BUSDFY2026 · Mar 31, 2026Cost of Goods Sold
493.13MUSDFY2026 · Mar 31, 2026Gross Profit
595.58MUSDFY2026 · Mar 31, 2026Operating Income
309.41MUSDvs all stocks (USD)
Pre-tax Income
257.50MUSDFY2026 · Mar 31, 2026Income Tax Expense
67.19MUSDFY2026 · Mar 31, 2026Net Income
190.30MUSDFY2026 · Mar 31, 2026EBIT
299.83MUSDFY2026 · Mar 31, 2026EBITDA (Income Statement)
331.11MUSDFY2026 · Mar 31, 2026Selling, General & Administrative
265.23MUSDFY2026 · Mar 31, 2026Non-operating Interest Expense
42.34MUSDFY2026 · Mar 31, 2026EPS (Basic)
3.93USDFY2026 · Mar 31, 2026EPS (Diluted)
3.91USDFY2026 · Mar 31, 2026Basic Shares Outstanding
48.46MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
48.46MSharesFY2026 · Mar 31, 2026Net Income from Continuing Operations
190.30MUSDFY2026 · Mar 31, 2026Operating Cash Flow
261.90MUSDFY2026 · Mar 31, 2026Free Cash Flow
250.72MUSDFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
63.87MUSDFY2026 · Mar 31, 2026Income Tax Paid
45.94MUSDFY2026 · Mar 31, 2026Interest Paid
43.84MUSDFY2026 · Mar 31, 2026Starting Profit (CF Statement)
190.30MUSDFY2026 · Mar 31, 2026Depreciation & Amortization
31.27MUSDFY2026 · Mar 31, 2026Deferred Taxes (CF)
22.70MUSDFY2026 · Mar 31, 2026Stock-based Compensation
10.84MUSDFY2026 · Mar 31, 2026Other Non-cash Items
19.98MUSDFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-3.69MUSDFY2026 · Mar 31, 2026Change in Accounts Payable (CF)
-151.00KUSDFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-9.35MUSDFY2026 · Mar 31, 2026Capital Expenditures
-11.18MUSDFY2026 · Mar 31, 2026Net Acquisitions
-123.74MUSDFY2026 · Mar 31, 2026Other Investing Activity
-1.93MUSDFY2026 · Mar 31, 2026Net Investing Cash Flow
-136.84MUSDFY2026 · Mar 31, 2026Long-term Debt Payments
-42.48MUSDFY2026 · Mar 31, 2026Net Short-term Debt Issuance
2.99MUSDFY2026 · Mar 31, 2026Common Stock Repurchase
-156.28MUSDFY2026 · Mar 31, 2026Other Financing Charges
-4.57MUSDFY2026 · Mar 31, 2026Net Financing Cash Flow
-200.35MUSDFY2026 · Mar 31, 2026Shares Outstanding
47.37MSharesUpdated Sep 28, 2026Float Shares
46.70MSharesUpdated Sep 28, 2026Shares Short
4.79MSharesUpdated Sep 28, 2026Short Ratio
10.45daysvs all stocks
Short % of Shares Outstanding
12.21%vs all stocks
% Held by Insiders
1.41%vs all stocks
% Held by Institutions
116.35%vs all stocks
Total Cash (MRQ)
89.13MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.88USDUpdated Sep 28, 2026Total Debt (MRQ)
2.07BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
1.08xCurrent Ratio (MRQ)
3.23xBook Value per Share (MRQ)
40.46USDUpdated Sep 28, 2026Total Assets
3.49BUSDvs all stocks (USD)
Total Current Assets
431.48MUSDFY2026 · Mar 31, 2026Total Liabilities
1.61BUSDFY2026 · Mar 31, 2026Total Non-current Assets
3.06BUSDFY2026 · Mar 31, 2026Total Non-current Liabilities
1.49BUSDFY2026 · Mar 31, 2026Total Current Liabilities
120.92MUSDFY2026 · Mar 31, 2026Cash & Cash Equivalents
63.87MUSDFY2026 · Mar 31, 2026Accounts Receivable
208.57MUSDFY2026 · Mar 31, 2026Inventory
159.13MUSDFY2026 · Mar 31, 2026Accounts Payable
22.79MUSDFY2026 · Mar 31, 2026Short-term Debt
12.55MUSDFY2026 · Mar 31, 2026Long-term Debt
1.03BUSDFY2026 · Mar 31, 2026Other Non-current Liabilities
5.58MUSDFY2026 · Mar 31, 2026Common Stock (Book)
562.00KUSDFY2026 · Mar 31, 2026Retained Earnings
1.75BUSDFY2026 · Mar 31, 2026Total Shareholders' Equity
1.89BUSDvs all stocks (USD)
Treasury Stock
439.30MUSDFY2026 · Mar 31, 202652-Week Low
42.62USDUpdated Sep 28, 202652-Week High
71.07USDUpdated Sep 28, 202652-Week Change
-24.76%vs all stocks
Beta
0.3310xvs all stocks
50-Day MA
50.26USDUpdated Sep 28, 2026200-Day MA
55.93USDUpdated Sep 28, 2026Avg 10-Day Volume
728.82KSharesUpdated Sep 28, 2026Avg 30-Day Volume
535.38KSharesUpdated Sep 28, 2026Diluted EPS (TTM)
3.57USDUpdated Sep 28, 2026Other Income / Expense
-9.57MUSDFY2026 · Mar 31, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Where is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.23: grey zoneSignificant
Altman Z-Score: 2.23
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $2.21B, above the global median of $1.18BNotable
Market cap (USD): 2,208,126,470Global Median: 1,180,223,658.953
Revenue is $1.1B, above the global median of $548.88MNotable
Revenue (USD): 1,104,884,992Global Median: 548,883,780.48
Levered free cash flow is $147.89M, above the global median of $18.73MNotable
Levered free cash flow (USD): 147,887,504Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Caplin Point Laboratories Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
BioCryst Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Verano Holdings Corp.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Aurinia Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zai Lab Limited
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Fujian Cosunter Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Pharvaris N.V.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Pfizer Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Ligachem Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Ways Electron Co. Ltd.
2 interpretationsPrice Below Mean With Profitability And Book ValueReceivables Heavy and Growing
Fortis Healthcare Ltd.
2 interpretationsPrice Below Mean With Profitability And Book ValueReceivables Heavy and Growing
Willfar Information Technology Co., Ltd.
2 interpretationsPrice Below Mean With Profitability And Book ValueReceivables Heavy and Growing